METHYLDOPA AND METHOSERPIDINE IN HYPERTENSION
- 1 January 1967
- journal article
- Published by Elsevier in The Lancet
- Vol. 289 (7482) , 141-142
- https://doi.org/10.1016/s0140-6736(67)91038-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- AUTOIMMUNE HÆMOLYTIC ANÆMIA ASSOCIATED WITH α-METHYLDOPA THERAPYThe Lancet, 1966
- INCIDENCE OF A POSITIVE DIRECT COOMBS TEST IN PATIENTS ON α-METHYLDOPAThe Lancet, 1966
- Isolation and characterization of mycoplasmas (PPLO) from patients with rheumatoid arthritis, systemic lupus erythematosus and reiter's syndromeArthritis & Rheumatism, 1965
- Methyldopa and Hydrochlorothiazide Compared with Reserpine and Hydrochlorothiazide in HypertensionBMJ, 1963
- Treatment of Severe Hypertension with MethyldopaBMJ, 1963
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- Pharmacological and Biochemical Effects of Some Reserpine DerivativesJournal of Pharmacy and Pharmacology, 1961
- MethoserpidineBMJ, 1961
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960
- Diagnostic Criteria for Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 1959